Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study

Condition:   Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis Interventions:   Drug: Alirocumab;   Drug: Atorvastatin Sponsor:   The First Affiliated Hospital with Nanjing Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials